< Back to Newsletter Archive

BIO Newsletter
BIO Newsletter: Biomedical Innovation Can Help Solve the Opioid Crisis, What’s Driving Health Care Spending?
SUBSCRIBE | VIEW ONLINE 11.02.2017
BIO NEWSLETTER
Providing Critical Information About the Industry
VISIT BIO.ORG
Biomedical Innovation Can Help Solve the Opioid Crisis
Long-term solutions to combating the opioid crisis will depend upon biomedical innovation and the development of novel and safer, next generation therapies to treat both pain and addiction. To get these new innovations to the patients whose lives depend on them, we must ensure that the policy and regulatory environment keeps pace with advances happening in the lab...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Blaming Pharma Won’t Lower Health Care Costs
HEALTH
spacer
What’s Driving Health Care Spending? Hint: Not Drug Costs arrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO IP Counsels Committee Conference
spacer
Register for the BIO IP Counsels Committee Conferencearrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO IP Counsels Committee Conference
Double border
BIO Action Double border
HEALTH HEALTH
FDA’s Historic Gene Therapy Approvals Could Be Beginning of the End of Blood Cancer
In his inaugural address this June as chairman of the world’s largest biotechnology industry group, CEO John Maraganore of Alnylam Pharmaceuticals dropped more than a few jaws with his prediction that we can “expect that all hematological malignancies will be cured in the next decade.”
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
Jim Greenwood Talks Biotech Innovation With Bloomberg Radio
While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau Chief Tom Moroney to discuss some of the big issues facing the healthcare industry, including drug pricing, healthcare reform and how biomedical innovation can help solve the opioid crisis…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
ICYMI: A Bipartisan Drug Cartel?
“As false as it is implausible.” That’s how a Wall Street Journal editorial describes a recent story by the Washington Post that alleges a conspiracy between the pharmaceutical industry and lawmakers to hamper the authority of the Drug Enforcement Administration…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
I&E INDUSTRIAL & ENVIRONMENTAL
BIO Applauds MLP Parity Act, Thanks Senate and House Sponsors
The bipartisan Master Limited Partnerships Parity Act of 2017 would level the playing field in the tax code by giving investors in renewable energy projects access to a decades-old corporate structure with a tax advantage now available only to fossil fuel projects…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
GMO AMSWERS Food And Agriculture
CRISPR-Cas9 Provides Opportunities for Smallholder Farmers
Gene editing technology holds potential to revolutionize the way scientists approach plant breeding, according to a new article in SeedWorld. A panel of expert scientists took on this subject at the recent Borlaug Dialogue conference in Des Moines, Iowa…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
GMO AMSWERS GMO AMSWERS
Listen Without Prejudice
GMO Answers had a booth at the 100th annual FNCE conference in Chicago this past week, and we did a lot of listening, and a lot of talking…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Bio Jobs
©2017 Biotechnology Innovation Organization. All rights reserved.
About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising
FOLLOW US: Follow us on Facebook Follow us on Twitter Follow us on LinkedIn Email us